stockrow
Friday 6 November 2026
Export CAPS’s income statement to Excel — free account
Capstone Therapeutics Corp.
CAPS Basic Materials Building Materials
Capstone Therapeutics Corp.’s revenue for fiscal 2025 (year ended December 2025) was $46.9 million, up 4.47% from fiscal 2024.
- Revenue
- +67.1%
- EPS
- +15.4%
- Free cash flow
- +73.4%
- Total debt
- +45.9%
Quarter to June 2026, against a year earlier
1.89
0.01
−0.53%
Follow CAPS
Alert me
Capstone Therapeutics Corp. (CAPS) P/E ratio
Capstone Therapeutics Corp. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 7 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CAPS Capstone Therapeutics Corp. | n/m |
| RETO ReTo Eco-Solutions, Inc. compare | n/m |
| TTAM Titan America SA compare | 12.3× |
| CPAC Cementos Pacasmayo S.A.A. compare | 14.2× |
| TGLS Tecnoglass Holdings Inc. compare | 15.8× |
| SMID Smith-Midland Corp. compare | 17.5× |
| KNF Knife River Corporation compare | 24.3× |
| LOMA Loma Negra Compania Industrial Argentina S.A. Sponsored ADR compare | 30.3× |
| RMIX Suncrete, Inc. compare | — |
| Building Materials industry median | 18.6× |
| Basic Materials sector median | 19.0× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)